GLYCOTOPE GmbH is a biotechnology company specialized in Glycobiology and Cellular Engineering. GLYCOTOPE combines its expertise in drug development, analytics, glycobiology, cell biology, molecular biology, biotechnology, antibody engineering and immunology to develop own innovative pharmaceutical therapeutics and nutrition additives and to offer state-of-the art services.GLYCOTOPE was founded in February 2001 by Dr. Steffen Goletz, Chief Scientific Officer of NEMOD Biotherapeutics and former head of a research group at the Max-Delbrück-Centre for Molecular Medicine in Berlin, and Dr. Andreas Eckert, CEO and founder of Eckert & Ziegler Strahlen- und Medizintechnik AG. The dynamic company is financed through its Research & Development services and a private financier.

Acquired Companies: NEMOD Biotherapeutics GmbH and_ Co. KG